The Kent and Canterbury Hospital, colloquially known among residents as the K+C, is a community hospital in Canterbury, Kent, England. It is managed by the East Kent Hospitals University NHS Foundation Trust.

During the past decade, Kent and Canterbury Hospital conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 16 clinical trials were completed, i.e. on average, 48.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 11 clinical trials were completed. i.e. 91.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kent and Canterbury Hospital" #1 sponsor was "University College, London" with 8 trials, followed by "Celgene" with 5 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "East Kent Hospitals University NHS Foundation Trust" with 4 trials sponsored and "Janssen Research & Development, LLC" with 4 trials sponsored. Other sponsors include 53 different institutions and companies that sponsored additional 47 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kent and Canterbury Hospital" #1 collaborator was "Cancer Research UK" with 6 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Cancer Trials Ireland" with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 56 trials.

According to Clinical.Site data, the most researched conditions in "Kent and Canterbury Hospital" are "Multiple Myeloma" (10 trials), "Lymphoma" (8 trials), "Prostate Cancer" (7 trials), "Breast Cancer" (6 trials) and "Leukemia" (4 trials). Many other conditions were trialed in "Kent and Canterbury Hospital" in a lesser frequency.

Most popular intervention types in "Kent and Canterbury Hospital" are "Drug" (64 trials), "Other" (13 trials), "Biological" (11 trials), "Procedure" (10 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (7 trials), "Placebo" (7 trials), "Bortezomib" (6 trials), "cyclophosphamide" (6 trials) and "Rituximab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Kent and Canterbury Hospital" are 72 trials for "All" genders, 10 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Kent and Canterbury Hospital". undefined are not yet recruiting, 13 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Kent and Canterbury Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Kent and Canterbury Hospital, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".